Related Experiment Video
Updated: Dec 22, 2025
Intratracheal Instillation of Stem Cells in Term Neonatal Rats
Published on: May 4, 2020
Hydrocortisone and bronchopulmonary dysplasia: variables associated with response in premature infants
Christie Clauss1, Stacey Thomas1,2, Igor Khodak3,4
1Department of Pharmacy, NYU Winthrop Hospital, New York University Langone Medical Center, Mineola, NY, USA.
Insights
Hydrocortisone effectively reduces respiratory support needs in premature infants with bronchopulmonary dysplasia (BPD). This treatment showed success in 50% of cases without major complications, warranting further study.
Area of Science:
- Neonatology
- Pediatric Pulmonology
- Pharmacology
Background:
- Bronchopulmonary dysplasia (BPD) is a chronic lung disease affecting premature infants.
- Respiratory support is crucial for managing BPD, but long-term outcomes can be challenging.
- Exploring effective pharmacological interventions is essential for improving BPD management.
Purpose of the Study:
- To evaluate the efficacy of hydrocortisone in reducing respiratory support in premature infants with developing BPD.
- To assess factors like IUGR, chorioamnionitis, and administration route on hydrocortisone's effectiveness.
- To review dexamethasone as a secondary treatment option.
Main Methods:
- Retrospective chart review of preterm infants requiring respiratory support.
- Inclusion of patients receiving hydrocortisone treatment.
- Analysis of successful extubation rates and complications.
Main Results:
- Hydrocortisone treatment led to successful extubation in 50% of intubated patients.
- No major complications were observed during hydrocortisone therapy.
- Maternal chorioamnionitis, IUGR, and route of administration did not significantly impact treatment response.
- Rescue dexamethasone was ineffective in patients who did not respond to hydrocortisone.
Conclusions:
- Hydrocortisone demonstrates effectiveness in decreasing respiratory support requirements for infants with developing BPD.
- The treatment appears safe, with no major complications reported in this cohort.
- Further randomized controlled trials are recommended to validate these findings.
Objective:
The primary objective was to evaluate hydrocortisone's efficacy for decreasing respiratory support in premature infants with developing bronchopulmonary dysplasia (BPD). Secondary objectives included assessment of the impact of intrauterine growth restriction (IUGR), maternal history of chorioamnionitis, side effects and route of administration associated with hydrocortisone's efficacy. Dexamethasone as second-line treatment to decrease respiratory support was reviewed.
Methods:
Retrospective chart review of preterm infants requiring respiratory support receiving hydrocortisone.
Results:
A total of 48 patients were included. Successful extubation was achieved in 50% of intubated patients after hydrocortisone treatment with no major complications. In our small study, history of maternal chorioamnionitis, IUGR or route of administration did not affect the response. Rescue dexamethasone after hydrocortisone therapy was ineffective in the ten patients who failed extubation following hydrocortisone.
Conclusion:
Hydrocortisone is effective in decreasing respiratory support in patients with developing BPD without major complications. Randomized studies are warranted to confirm our findings.
More Related Videos
05:31Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
09:36Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Related Concept Videos
01:26COPD: Management Using Bronchodilators and Corticosteroids
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
01:26Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:30Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:30Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
01:20Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.